Posts

Quant? Savant? Nah That's Just Shane

Building a Simple Functional Quant System Building a Simple Functional Quant System A fledgling investor’s attempt to turn intuition into structured probability. From Prediction to Structure Most trading systems fail not because the ideas are wrong, but because they rely too heavily on predicting what the market will do next. We are not trying to predict the market. We are trying to structure exposure to likely outcomes. Instead of asking whether a trade will work, we ask what conditions tend to produce favorable outcomes and how to express that exposure repeatedly. The Bucket Model: Multiple Paths to the Same Outcome Rather than relying on a single setup, we build multiple “buckets” of opportunity: Trend continuation setups Mean reversion structures Volatility expansion trades Breakout and momentum systems Each bucket represents a different pathway to the same objective: positive expectancy over time. You are not betting on one door. You...
Post a Comment
Read more

Lightwave

Post a Comment
Read more

RGTI Revisit

RGTI Rigetti Computing: High-Volume Breakout Swing Setup RGTI Rigetti Computing: High-Volume Breakout Swing Setup Published: June 29, 2026 • Personal Trading Playbook • Quantum Computing Sector 57/100 Conviction Score 1 : 2.6 Risk / Reward +20.8% Expected Value 2.5–4% Position Size Executive Summary Rigetti Computing (RGTI) is showing a technically constructive breakout structure supported by rising volume, neutral RSI conditions, and improving institutional attention following federal CHIPS Act-related funding alignment. The stock is transitioning from speculative compression into a momentum expansion phase. Price action near the $21 zone represents a critical decision point: sustained holds above breakout levels may trigger continuation toward $24–$28, while failure would likely return price to the $18–$19 support band. AI Conviction Snapshot Conviction Score: 57 / 100...
Post a Comment
Read more

GOVX Biohazard

GOVX — Playbook & Thesis GOVX — Playbook & Thesis Published: June 28, 2026 • Personal Trading Playbook 51/100 Conviction Score 1:1.2 Risk / Reward +31.1% Expected Value 1.5–2.5% Suggested Alloc. AI Execution Summary: GOVX shows a moderate-conviction setup featuring an asymmetric risk-to-reward edge of 1:1.8 blended. Price action has held the recent daily low support zone while remaining below declining weekly EMAs, creating a reload opportunity for a measured bounce. Timing is highly optimized with price floating just 1.5-5.6% from the planned structural entry zone of $1.25-1.30, supported by neutral RSI readings and the absence of immediate breakdown catalysts in the near term. Trade Execution Matrix Scenario Entry Trigger Exit / Target Return % Probability Sc...
Post a Comment
Read more

Bio Hazards

GOVX • Corrected Trading Playbook • June 2026 GOVX PLAYBOOK June 27, 2026 v2.1 • Corrected GeoVax Labs GOVX Corrected Asymmetric Swing Playbook CURRENT REFERENCE $1.32 +0.8% ...
Post a Comment
Read more

Not Force Feeding

In the trading world, there is a distinct class of market participants who intentionally reject slow-moving patience. They chase velocity, hunt for momentum, and exploit rapid price inefficiencies. When executed by an elite operator, high-velocity trading can be incredibly lucrative—proving that sitting on your hands isn't always the most profitable route. But to play in that fast lane and survive, you have to be better than 97% of the market . You need razor-sharp execution, flawless risk parameters, and zero ego. The danger arises when a trader possesses the hard-headed conviction of a high-velocity pro, but lacks the actual discipline to back it up. That is where the lines blur, and where a calculated strategy degrades into a high-stakes gamble. The Fine Line Between Aggressive and Arbitrary There is a massive, structural difference between an aggressive trader weaponizing speed and a stubborn trader choking their own account: ...
Post a Comment
Read more

Viridian Therapeutics (VRDN) received FDA approval for veligrotug

VRDN — Updated Playbook & Thesis (Post-Approval) VRDN — Updated Playbook & Thesis (Post-Approval) Published: June 27, 2026 • Personal Trading Playbook 75/100 Conviction Score 1:3 Risk / Reward +8-12% Near-Term Expected 3-5% Suggested Alloc. AI Execution Summary (Updated): Viridian Therapeutics (VRDN) received FDA approval for veligrotug (Lumvoa™ / veligrotug-vvze) on June 26, 2026 — ahead of the June 30 PDUFA — for Thyroid Eye Disease (TED), with immediate commercial launch. The label covers both active and chronic TED, a major win vs. Tepezza. Management hosts a conference call Monday, June 29 at 8:00 a.m. ET. The stock closed June 26 at $17.90 (up ~2.93% on volume). With regulatory risk removed, strong cash (> $1B post-May raise), and positive subcutaneous data already in hand, this shifts to a post-approval execution / momentu...
Post a Comment
Read more

Fermi Medium Risk High Returns?

FRMI — Playbook & Thesis FRMI — Playbook & Thesis Published: June 27, 2026 • Personal Trading Playbook 48/100 Conviction Score 1:2+ Target Risk/Reward +35% Blended Upside 1–3% Suggested Alloc. AI Execution Summary: FRMI presents a solid swing opportunity in the AI power infrastructure theme. Closed at $9.49 (+7.84%) on strong volume (~28.6M shares) after governance clarity. Positioned for continuation if it holds key support, with asymmetric upside to analyst targets amid hyperscale power demand. Trade Execution Matrix Trade Scenario Entry Zone Stop Loss Target 1 Target 2 ...
Post a Comment
Read more

NCPL 🎰 This is Skillful Gambling Territory

NCPL (Netcapital Inc.): High Borrow Costs, Low-Float Dynamics, and What Similar Setups Have Shown Historically NCPL (Netcapital Inc.): High Borrow Costs, Low-Float Dynamics, and What Similar Setups Have Shown Historically Data as of midday June 26, 2026. This is an analytical overview for educational and research purposes only. Current Snapshot NCPL is a microcap fintech stock (NASDAQ: NCPL) trading around the 0.55 area after a +5.7% intraday move on roughly 558k shares of volume. The day’s range has been approximately 0.51 – 0.60 . Key stats include: Market cap: ≈ $4.3M Shares outstanding: ≈ 7.85M Free float: ≈ 4.4M shares 52-week range: 0.3115 – 8.75 Average volume (3M): ≈ 3.7M shares EPS (TTM): –11.41 Book value per share: ≈ 3.155 (trading at roughly 0.17x book) Warrants (NCPLW) have traded near 0.0266 . TradingView chart: NASDAQ:NCPL ...
Post a Comment
Read more